Amyloid-beta-activated human microglial cells through ER-resident proteins

Area of Science:

• Neuroscience
• Immunology
• Proteomics

Background:

• Microglial activation is central to neuroinflammation in Alzheimer's disease (AD).
• Amyloid beta (Aβ) peptide drives microglial activation and chronic inflammation in AD.
• Limited proteomic data exists for microglia in AD models.

Purpose of the Study:

• To conduct a proteomic analysis of Aβ-stimulated human microglial cells.
• To identify key molecular biomarkers of microglial activation in response to Aβ.
• To explore potential therapeutic targets for AD based on microglial activation pathways.

Main Methods:

• Utilized stable isotope labeling with amino acids in cell culture (SILAC) for quantitative proteomic analysis.
• Employed liquid chromatography-tandem mass spectrometry (LC-MS/MS) for protein identification and quantification.
• Validated proteomic findings using immunostaining, PCR, ELISA, and Western blot.

Main Results:

• Identified 60 proteins with a ≥1.5 fold change in abundance upon Aβ stimulation.
• Revealed endoplasmic reticulum (ER)-resident proteins (SERPINH1, PDIA6, PDIA3, PPIB) as key biomarkers.
• Confirmed the role of these ER proteins in human microglial activation.

Conclusions:

• ER proteins are essential in Aβ-induced human microglial activation.
• These ER proteins represent potential molecular therapeutic targets for Alzheimer's disease.
• This study provides novel insights into the proteomic landscape of activated microglia in AD.